<html>
<head>
<meta charset='utf-8'>
<title>Daily Biotech & Science Report (2025-05-19)</title>
<style>

             body { font-family: Arial, sans-serif; margin: 20px; background-color: #f4f4f4; }
             .container { max-width: 800px; margin: auto; background: #fff; padding: 20px; }
             h1, h2, h3 { color: #333; }
             .news-item, .paper-item { border: 1px solid #ddd; padding: 15px; margin-bottom: 15px; border-radius: 5px; background: #fafafa; }
             .source-date { font-size: 0.9em; color: #666; }
             a { color: #1a0dab; text-decoration: none; }
             a:hover { text-decoration: underline; }
         
</style>
</head>
<body>
<div class='container'>
<h1>Daily Biotech & Science Report (2025-05-19)</h1>
<h2>Biotech Industry & Market News</h2>
<div class='news-item'>
<h3>10x Settles Bruker, Vizgen Patent Lawsuits</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>10x Genomics has settled patent infringement lawsuits with a pair of rivals, Bruker and Vizgen, through settlements that could reshape competition within the emerging single-cell and spatial genomics fields. The post 10x Settles Bruker, Vizgen Patent Lawsuits appeared first on GEN - Genetic Engin...</p>
<p><a href='https://www.genengnews.com/topics/omics/10x-settles-bruker-vizgen-patent-lawsuits/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>EvoCAST Harnesses CRISPR-Linked Bacterial Transposes to Insert Genes Into Human Cells</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-19</em></p>
<p>The new CRISPR system uses laboratory engineered versions of transposases from Pseudoalteromonas bacteria that were evolved over several generations to efficiently insert copies of healthy genes into human cells at therapeutically useful levels. The post EvoCAST Harnesses CRISPR-Linked Bacterial ...</p>
<p><a href='https://www.genengnews.com/topics/genome-editing/evocast-harnesses-crispr-linked-bacterial-transposes-to-insert-genes-into-human-cells/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Novavax wins FDA approval of Covid shot after delay, with restrictions</h3>
<p class='source-date'><em>Endpoints News • 2025-05-19</em></p>
<p>After more than a month of waiting and negotiations with US regulators, Novavax has gained FDA approval for its Covid shot. But it’s for a tighter population than the company had asked for, and signals ...</p>
<p><a href='https://endpts.com/novavax-wins-fda-approval-of-covid-shot-after-delay-with-restrictions/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Patents</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-18</em></p>
<p>Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are reviewing the complaint and look forward to defending our innovations in court.” The post Illumina Sues Element Biosciences, Alleging Infringement of Flow Cell, Imaging Pate...</p>
<p><a href='https://www.genengnews.com/topics/omics/illumina-sues-element-biosciences-alleging-infringement-of-flow-cell-imaging-patents/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A</h3>
<p class='source-date'><em>GEN – Genetic Engineering and Biotechnology News • 2025-05-18</em></p>
<p>BioMarin agreed to shell out approximately $270 million for Inozyme Pharma, a developer whose treatments target the PPi-adenosine pathway, a key regulator of bone health and blood vessel function. The post StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A appeared first on GEN - Ge...</p>
<p><a href='https://www.genengnews.com/topics/drug-discovery/stockwatch-with-inozyme-buyout-biomarin-pursues-growth-via-ma/' target='_blank'>Read more</a></p>
</div>
<div class='news-item'>
<h3>What we know about ‘most favored nation’; GSK’s $1.2B MASH deal; Bayer details staff cuts; and more</h3>
<p class='source-date'><em>Endpoints News • 2025-05-17</em></p>
<p>Happy Saturday and welcome back to Endpoints Weekly! We had a flurry of news this week, so let’s dive in. Our team has the latest news and analysis around the Trump administration’s executive order intended ...</p>
<p><a href='https://endpts.com/what-we-know-about-most-favored-nation-gsks-1-2b-mash-deal-bayer-details-staff-cuts-and-more/' target='_blank'>Read more</a></p>
</div>
<h2>Microbiome & Antimicrobials News</h2>
<p>No recent microbiome news available today.</p>
<hr>
<h2>Scientific Papers</h2>
<h3>Biotech & Microbiome Focus Papers</h3>
<div class='paper-item'>
<h4>Antimicrobial prescription practices and opinions regarding antimicrobial resistance among veterinarians in Palestine 2024.</h4>
<p class='source-date'><em>Alzuheir Ibrahim M, Fayyad Adnan, Thabet Ahmed | BMC veterinary research • 2025-05-19</em></p>
<p><strong>Abstract:</strong> BACKGROUND: Antimicrobial use (AMU) by veterinarians is crucial for animal health management worldwide. Its extensive and improper use with insufficient monitoring has raised concerns about antimicrobial resistance (AMR). Veterinarians' opinions on antimicrobial agents and AMR are crucial in shap...</p>
<p><a href='https://doi.org/10.1186/s12917-025-04826-5' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Antimicrobial resistance in northern Australia: the HOTspots surveillance and response program annual epidemiology report 2022.</h4>
<p class='source-date'><em>Wozniak Teresa M, Young Alys R, Shausan Aminath et al. | Communicable diseases intelligence (2018) • 2025-05-19</em></p>
<p><strong>Abstract:</strong> BACKGROUND: The HOTspots surveillance and response program monitors antimicrobial resistance (AMR) in selected bacterial pathogens across three jurisdictions in northern Australia. In 2022, the program collected data from 164 community healthcare clinics and 50 hospitals to assess AMR trends and ...</p>
<p><a href='https://doi.org/10.33321/cdi.2025.49.030' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Perceived barriers of dairy producers to the adoption of selective antimicrobial therapies for non-severe clinical mastitis and at dry-off in dairy cattle: A focus group study in Ontario, Canada.</h4>
<p class='source-date'><em>Brunt M W, Ehigbor T F, Ritter C et al. | Journal of dairy science • 2025-05-16</em></p>
<p><strong>Abstract:</strong> Prudent antimicrobial use (AMU) in the dairy industry is crucial as it affects animal health, welfare, and could help to slow the development of antimicrobial resistance. There is a need to adopt selective AMU. However, the barriers to adoption of selective antimicrobial use for the management of...</p>
<p><a href='https://doi.org/10.3168/jds.2025-26491' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Effects of feeding a simulated waste milk on growth, health, fecal microbiota, and antibiotic resistance in dairy heifer calves.</h4>
<p class='source-date'><em>Flynn Anna, Barton Wiley, McAloon Catherine et al. | Journal of dairy science • 2025-05-16</em></p>
<p><strong>Abstract:</strong> Feeding waste milk, a common practice in dairy farming, exposes calves to subtherapeutic levels of antimicrobials, potentially contributing to antibiotic resistance-a growing concern globally. Many dairy farmers, including those in Ireland, continue this practice, feeding waste milk from antibiot...</p>
<p><a href='https://doi.org/10.3168/jds.2024-26062' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Occurrence and genotypic characterization of selected multidrug-resistant ESKAPE-E pathogens isolated from integrated smallholder fresh produce farms.</h4>
<p class='source-date'><em>Viviers Sheldon, Richter Loandi, Featherston Jonathan et al. | Journal of food protection • 2025-05-16</em></p>
<p><strong>Abstract:</strong> Antimicrobial resistance (AMR) ranks among the top ten global public health threats, with extended-spectrum β-lactamase (ESBL)-producing Enterobacterales and Pseudomonas aeruginosa emerging as multidrug-resistant (MDR) priority pathogens. This study aimed to evaluate the presence and characterist...</p>
<p><a href='https://doi.org/10.1016/j.jfp.2025.100543' target='_blank'>View Paper</a></p>
</div>
<h3>Synthetic & Molecular Biology Papers</h3>
<div class='paper-item'>
<h4>ZC3H12D gene expression exhibits dual effects on the development and progression of lung adenocarcinoma.</h4>
<p class='source-date'><em>Zheng Yuansi, Zhang Yuhuan, Li Jieyi et al. | Scientific reports • 2025-05-18</em></p>
<p><strong>Abstract:</strong> While precision oncology requires robust biomarkers, current predictors for lung adenocarcinoma (LUAD) often show limited clinical utility. This study investigates the multifaceted roles of ZC3H12D, a novel immunomodulatory molecule, in LUAD progression and tumor microenvironment regulation. Mult...</p>
<p><a href='https://doi.org/10.1038/s41598-025-02163-z' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>A novel mouse model for X-linked Alport syndrome induced by splicing mutation in the Col4a5 gene.</h4>
<p class='source-date'><em>Ye Zhitao, Lu Di, Zhou Shumin et al. | Scientific reports • 2025-05-18</em></p>
<p><strong>Abstract:</strong> Alport syndrome is a hereditary kidney disease with significant variations in onset and prognosis. While 80-85% of cases are due to pathogenic variants in the COL4A5 gene, there is a notable lack of mouse models with Col4a5 mutations for basic research. Our research presents an 8-year-old child w...</p>
<p><a href='https://doi.org/10.1038/s41598-025-01663-2' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Piperlongumine Inhibits Malignant Progression of Esophageal Squamous Cells Through the PI3K/AKT Signaling Pathway.</h4>
<p class='source-date'><em>Wang Jun, Chu Yueming, Hu Guangbing et al. | Biochemical genetics • 2025-05-18</em></p>
<p><strong>Abstract:</strong> To examine the impact of Piperlongumine (PL) on the proliferation, migration, invasion, cell cycle progression, and apoptosis in esophageal squamous cell carcinoma (ESCC) cells, as well as to elucidate the underlying molecular mechanisms. The suppressive effects of PL on the viability of ESCC cel...</p>
<p><a href='https://doi.org/10.1007/s10528-025-11139-7' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>An energy metabolism-related signature relevant to the tumor immune microenvironment in HNSCC.</h4>
<p class='source-date'><em>Zhu Kaiyu, Bai Yang, Lin Changwei et al. | Discover oncology • 2025-05-18</em></p>
<p><strong>Abstract:</strong> The importance of energy metabolism in cancer was explored by accumulating studies. Energy metabolism can affect the cellular activities of tumors. However, there is few research exploring the role of energy metabolism in tumor immune microenvironment. In this context, we constructed a novel ener...</p>
<p><a href='https://doi.org/10.1007/s12672-025-02652-7' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Alcohol consumption and esophageal cancer risk: unveiling DLEU2 as a key immune modulator through Mendelian randomization and transcriptomic analysis.</h4>
<p class='source-date'><em>Qu Kailin, Gu Jingyan, Xu Zhi et al. | Discover oncology • 2025-05-18</em></p>
<p><strong>Abstract:</strong> Esophageal cancer (EC) is a leading cause of cancer-related mortality globally, with alcohol consumption being a significant risk factor. However, the genetic and molecular mechanisms linking alcohol intake to EC remain unclear. This study utilized Mendelian randomization analysis to establish a ...</p>
<p><a href='https://doi.org/10.1007/s12672-025-02660-7' target='_blank'>View Paper</a></p>
</div>
<h3>Bacteriophage Research Papers</h3>
<div class='paper-item'>
<h4>Characterization of a virulent phage, P12L (genus Drulisvirus), targeting Klebsiella pneumoniae capsule type K2.</h4>
<p class='source-date'><em>Rollon Wendy Dayang, Dean Tay Darren, Idris Sharifah Ishaziah Mohd et al. | Archives of virology • 2025-05-16</em></p>
<p><strong>Abstract:</strong> A virulent bacteriophage, P12L, infecting hypermucoviscous Klebsiella pneumoniae of capsule-type K2 was characterized. The phage was found to have podovirus-like morphology, with an icosahedral head and a short tail. It exhibited efficient adsorption with a burst size of 183 PFU/cell. The viral g...</p>
<p><a href='https://doi.org/10.1007/s00705-025-06320-7' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii.</h4>
<p class='source-date'><em>Sherif Mahmoud M, Abdelaziz Neveen A, Alshahrani Mohammad Y et al. | Scientific reports • 2025-05-17</em></p>
<p><strong>Abstract:</strong> The urgent threat of carbapenem-resistant Acinetobacter baumannii (CRAB) necessitates the development of new antimicrobial strategies. Bacteriophage (phage) therapy is one of the most promising alternative strategies that can be implemented to combat multidrug-resistant (MDR) bacterial infections...</p>
<p><a href='https://doi.org/10.1038/s41598-025-99788-x' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Bacteriophages enhance the transformation of dissolved organic matter during vermicomposting of sludge.</h4>
<p class='source-date'><em>Zhu Licheng, Huang Kui, Bai Tiegen et al. | Bioresource technology • 2025-05-16</em></p>
<p><strong>Abstract:</strong> Vermicomposting is an eco-friendly technology for treating sewage sludge, however its efficiency in transforming biological material is often constrained. This study investigates the potential of bacteriophages to enhance the transformation of dissolved organic matter (DOM) during sludge vermicom...</p>
<p><a href='https://doi.org/10.1016/j.biortech.2025.132694' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Genomic characterization of the novel bacteriophage PfAn1 from Lake Baikal, infecting Pseudomonas fluorescens.</h4>
<p class='source-date'><em>Gorshkova Anna, Belykh Olga, Tikhonova Irina et al. | Archives of virology • 2025-05-16</em></p>
<p><strong>Abstract:</strong> We isolated a novel bacteriophage from Lake Baikal that infects Pseudomonas fluorescens. Transmission electron microscopy revealed that phage PfAn1 has a head with a diameter of 50 nm and a short tail. Its genome is 39,156 bp in length with a GC content of 57%. It is predicted to contain 53 open ...</p>
<p><a href='https://doi.org/10.1007/s00705-025-06315-4' target='_blank'>View Paper</a></p>
</div>
<div class='paper-item'>
<h4>Phage-antibiotic synergy to combat multidrug resistant strains of Gram-negative ESKAPE pathogens.</h4>
<p class='source-date'><em>Morris Tinta Carmen, Reyneke Brandon, Khan Sehaam et al. | Scientific reports • 2025-05-18</em></p>
<p><strong>Abstract:</strong> Bacteriophage-antibiotic-synergy (PAS) was investigated to target Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter baumannii and Enterobacter cloacae. Whole genome sequencing indicated that bacteriophage KPW17 targeting K. pneumoniae, clustered with genus Webervirus, ECSR5 targeting E...</p>
<p><a href='https://doi.org/10.1038/s41598-025-01489-y' target='_blank'>View Paper</a></p>
</div>
<h3>Skin Microbiome & Disease Papers</h3>
<p>No recent papers on Skin Microbiome & Disease available today.</p>
<hr>
<p><em>Report generated on 2025-05-19</em></p>
</div>
</body>
</html>